|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0735 | (2010.01) |
| C12N2501/195 | (2013.01) | ||
| C12N 5/074 | (2010.01) | ||
| C12N2527/00 | (2013.01) | ||
| C12N2501/105 | (2013.01) | ||
| C12N2501/999 | (2013.01) | ||
| C12N2501/16 | (2013.01) | ||
| C12N 5/0696 | (2013.01) | ||
| C12N 5/0606 | (2013.01) | ||
| C12N2501/235 | (2013.01) | ||
| C12N2501/155 | (2013.01) | ||
| C12N2533/90 | (2013.01) | ||
| C12N2501/115 | (2013.01) | ||
| C12N2501/727 | (2013.01) |
| (11) | Number of the document | 2730649 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13191140.6 |
| Date of filing the European patent application | 2013-10-31 | |
| (97) | Date of publication of the European application | 2014-05-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201213672688 | 2012-11-08 | US |
| (72) |
Schulz, Thomas , US
|
| (73) |
VIACYTE, INC. ,
3550 General Atomics Court
2-503, San Diego, CA 92121,
US
|
| (54) | Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |
| Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |